Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-02-29 Sale |
2024-03-04 6:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
10,000 | $29.84 | $298,450 | 21,517 (Direct) |
View |
2024-02-29 Sale |
2024-03-04 6:48 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
4,100 | $29.33 | $120,257 | 18,680 (Direct) |
View |
2024-02-16 Sale |
2024-02-21 8:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
3,576 | $29.84 | $106,701 | 71,871 (Direct) |
View |
2024-02-16 Sale |
2024-02-21 8:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
7,132 | $29.84 | $212,805 | 477,086 (Indirect Direct) |
View |
2024-02-16 Sale |
2024-02-21 8:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
3,238 | $29.84 | $96,615 | 46,062 (Direct) |
View |
2024-02-16 Sale |
2024-02-21 8:54 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
20,272 | $29.84 | $604,876 | 1,223,913 (Indirect Direct) |
View |
2024-01-22 Sale |
2024-01-23 4:22 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
638 | $27.2 | $17,356 | 10,159 (Direct) |
View |
2023-11-15 Sale |
2023-11-16 7:24 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
20,000 | $22.53 | $450,646 | 1,296,497 (Indirect) |
View |
2023-10-20 Sale |
2023-10-25 09:38 am |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
564 | $17.06 | $9,623 | 8,760 (Direct) |
View |
2023-02-17 Sale(A) |
2023-10-20 6:37 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,076 | $19.06 | $20,509 | 18,842 (Direct) |
View |
2023-09-28 Sale |
2023-10-02 9:02 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
14,989 | $21.07 | $315,744 | 1,316,497 (Indirect) |
View |
2023-08-17 Sale |
2023-08-21 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
1,534 | $15.47 | $23,733 | 320,384 (Indirect Direct) |
View |
2023-08-17 Sale |
2023-08-21 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
4,767 | $15.47 | $73,750 | 931,092 (Indirect Direct) |
View |
2023-08-17 Sale |
2023-08-21 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
284 | $15.47 | $4,394 | 5,570 (Direct) |
View |
2023-07-20 Sale |
2023-07-24 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
573 | $19.03 | $10,906 | 7,129 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-02-29 Exercise |
2024-03-04 6:54 pm |
N/A 2028-01-28 |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
10,000 | $12.55 | 21,517 (Direct) |
View |
2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
65,735 | $0 | 71,871 (Direct) |
View |
2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
131,471 | $0 | 477,086 (Direct) |
View |
2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
32,867 | $0 | 46,062 (Direct) |
View |
2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | White Mark Andrew Chief Medical Officer |
43,823 | $0 | 120,485 (Direct) |
View |
2024-02-16 Option Award |
2024-02-21 8:54 pm |
N/A 2034-02-16 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
262,913 | $0 | 1,223,913 (Direct) |
View |
2024-02-14 Exercise |
2024-02-16 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
93,656 | $0 | 1,090,659 (Direct) |
View |
2024-02-14 Exercise |
2024-02-16 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
52,378 | $0 | 412,975 (Direct) |
View |
2024-02-14 Exercise |
2024-02-16 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
9,712 | $0 | 29,079 (Direct) |
View |
2024-02-14 Exercise |
2024-02-16 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
12,548 | $0 | 29,495 (Direct) |
View |
2024-01-18 Exercise |
2024-01-22 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,586 | $0 | 18,729 (Direct) |
View |
2023-12-07 Option Award |
2023-12-12 8:51 pm |
N/A 2033-12-07 |
ROCKET PHARMACEUTICALS INC. | RCKT | Woods Keith Director |
32,482 | $0 | 32,482 (Direct) |
View |
2023-11-14 Exercise |
2023-11-16 7:17 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,989 | $0 | 347,656 (Direct) |
View |
2023-11-14 Exercise |
2023-11-16 7:09 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 978,969 (Direct) |
View |
2023-11-14 Exercise |
2023-11-16 6:58 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
725 | $0 | 13,113 (Direct) |
View |
2023-10-18 Exercise(A) |
2023-10-20 6:37 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,586 | $0 | 18,842 (Direct) |
View |
2023-10-05 Exercise |
2023-10-10 4:11 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,333 | $0 | 323,717 (Indirect) |
View |
2023-08-28 Other |
2023-08-30 4:15 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
500,000 | $22.05 | 20,157,605 (Indirect) |
View |
2023-08-28 Other |
2023-08-30 4:15 pm |
2018-08-27 2023-08-28 |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
2 | $0 | 20,157,605 (Indirect) |
View |
2023-08-28 Other |
2023-08-30 4:15 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
500,000 | $15.87 | 20,157,605 (Indirect) |
View |
2023-08-14 Exercise |
2023-08-15 4:17 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
725 | $0 | 12,207 (Direct) |
View |
2023-08-14 Exercise |
2023-08-15 4:16 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,989 | $0 | 345,911 (Direct) |
View |
2023-08-14 Exercise |
2023-08-15 4:06 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 983,736 (Direct) |
View |
2023-07-18 Exercise |
2023-07-20 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,586 | $0 | 18,806 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:48 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director |
25,850 | $0 | 25,850 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:48 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner |
25,850 | $0 | 29,440 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:48 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner |
3,590 | $13.93 | 29,440 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Malik Fady Ibraham Director |
25,850 | $0 | 25,850 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
25,850 | $0 | 28,722 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
2,872 | $13.93 | 28,722 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director |
25,850 | $0 | 25,850 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
25,850 | $0 | 30,876 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
5,026 | $13.93 | 30,876 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director |
25,850 | $0 | 29,440 (Direct) |
View |
2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director |
3,590 | $13.93 | 29,440 (Direct) |
View |